FDA is stopping work on several key rules including those regulating compounding, direct-to-consumer prescription drug advertising, child-focused tobacco sales, dietary supplement manufacturing practices and food safety testing, according to a list published Friday (July 21) by the White House Office of Management and Budget. The newly released inactive list of the Unified Agenda is the Trump administration's first time identifying rules that federal agencies are not actively working to release. Public Citizen took issue with FDA's placement of two regulations...